(Press-News.org) NEW YORK, NY (March 18, 2021)--Therapies that soothe inflammation could be an effective way to prevent heart disease in people with a common age-related blood condition, according to a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons.
The researchers identified how the blood condition, called clonal hematopoiesis, worsens atherosclerosis, and their findings suggest that an anti-inflammatory drug previously tested in a wider population of people with cardiovascular disease may have potential if used only in those with clonal hematopoiesis.
"The main message from our research is that anti-inflammatory therapies for atherosclerotic heart disease may be particularly effective in patients with clonal hematopoiesis," says Alan Tall, MD, the Tilden Weger Bieler Professor of Medicine, the study's co-senior author with Nan Wang, MD, associate professor of medical sciences (in medicine).
Their study was published online March 17 in Nature.
Aging Contributes to Heart Disease
Although great strides have been made in reducing atherosclerotic heart disease with therapies such as statins that reduce cholesterol, many people still have increased disease despite these current treatments.
"Over the years, researchers have learned that the aging process itself is a major contributor to cardiovascular disease," says Trevor P. Fidler, PhD, associate research scientist in medicine, the study's first author. "But how aging itself can lead to heart disease--and how it could be prevented--is not well understood."
Common Blood Condition Increases Heart Disease
In the new study, the researchers took a close look at a common blood condition, called clonal hematopoiesis, that is associated with aging.
Clonal hematopoiesis is thought to occur in roughly 10% of people over age 70, and most people have no symptoms. But researchers recently realized that the condition--for unknown reasons--raises the risk of heart disease by 40%.
Clonal hematopoiesis occurs when hematopoietic (blood) stem cells acquire mutations. As people age, each hematopoietic stem cell acquires genetic mutations, though most of these mutations have no impact. But in clonal hematopoiesis, some mutations supercharge the stem cell so that it produces a greater number of blood cells compared with other stem cells.
Study of Mice Reveals Source of Extra Heart Risk
Clonal hematopoiesis usually arises when one of four specific genes is mutated. The Columbia team looked specifically at JAK2, which imparts the strongest risk of premature coronary artery disease.
In atherosclerosis, white blood cells called macrophages accumulate in plaques and proliferate as the plaque grows.
In studies of mice, the researchers found that the JAK2 mutations led to a number of changes in macrophages that increased macrophage proliferation, increased inflammation in the atherosclerotic plaques, and enhanced the plaque's necrotic core.
"We know in humans that such regions are associated with unstable plaques, which can rupture, causing heart attacks or strokes," Fidler says.
The researchers also traced the molecular mechanisms that led to these changes, including increased activation of the AIM2 inflammasome, a complex of proteins that induces inflammation.
Targeting Inflammasome May Reduce Cardiovascular Risk
Inhibiting various components of the inflammasome improved the stability of the plaques, as did inhibition of IL-1ß, a product of the inflammasome.
Though an IL-1ß inhibitor called canakinumab reduced cardiovascular events in a clinical trial, the drug was associated with a small risk of infection and has not been marketed to reduce cardiovascular disease.
"If instead we take a precision medicine approach and only use canakinumab to treat patients with JAK-driven clonal hematopoiesis," Fidler says, "we may increase the cardiovascular benefit. Even if infection risk remains unchanged, we may provide an overall benefit to this specific population."
INFORMATION:
More Information
The study is titled "The Aim2 inflammasome exacerbates atherosclerosis in clonal hematopoiesis."
All authors: Trevor Fidler (Columbia), Chenyi Xue (Columbia), Mustafa Yalcinkaya (Columbia), Brian Hardaway (Columbia), Sandra Abramowicz (Columbia), Tong Xiao (Columbia), Wenli Liu (Columbia), David G. Thomas (Columbia), Mohammad Ali Hajebrahimi (Ludwig Maximilian University and German Center for Cardiovascular Research), Joachim Pircher (Ludwig Maximilian University and German Center for Cardiovascular Research), Carlos Silvestre-Roig (German Center for Cardiovascular Research and IPEK, Munich), Andriana G. Kotini (Icahn School of Medicine at Mount Sinai), Larry L. Luchsinger (Columbia), Ying Wei (Columbia), Marit Westerterp (Columbia and University of Groningen), Hans-Willem Snoeck (Columbia), Eirini P. Papapetrou (Icahn School of Medicine at Mount Sinai), Christian Schulz (Ludwig Maximilian University and German Center for Cardiovascular Research), Steffen Massberg (Ludwig Maximilian University and German Center for Cardiovascular Research), Oliver Soehnlein (Ludwig Maximilian University, German Center for Cardiovascular Research, and Karolinksa Institute), Benjamin Ebert (Dana-Farber Cancer Institute), Ross L. Levine (Memorial Sloan Kettering Cancer Center), Muredach P. Reilly (Columbia), Peter Libby (Harvard Medical School), Nan Wang (Columbia), and Alan R. Tall (Columbia).
The research was supported by the Leducq Foundation, the National Institutes of Health (grants HL118567, HL155431, HL148071, HL137663, CA108671, CA008748, HL080472, HL134892, R01HL137219, and R01CA225231), a Columbia Clinical and Translational Science Award, the New York State Stem Cell Board, a Scholar Award from the Leukemia and Lymphoma Society, the German Research Foundation, the German Center for Cardiovascular Research, and the German Ministry of Education and Research.
The authors' competing interests are listed in the online version of the paper.
Columbia University Irving Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the Vagelos College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Irving Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest faculty medical practices in the Northeast. For more information, visit cuimc.columbia.edu or columbiadoctors.org.
A Russian-German research team has created a quantum sensor that grants access to measurement and manipulation of individual two-level defects in qubits. The study by NUST MISIS, Russian Quantum Center and the Karlsruhe Institute of Technology, published in npj Quantum Information, may pave the way for quantum computing.
In quantum computing the information is encoded in qubits. Qubits (or quantum bits), the quantum mechanical analogue of a classical bit, are coherent two-level systems. A leading qubit modality today superconducting qubits based on the Josephson junction. That is the kind of qubit IBM and Google used in their quantum processors. However, scientists are still searching for the perfect qubit -- the one that can be precisely measured and controlled, ...
Researchers are developing new autonomous technologies that can help people check that isolated elderly family members are okay.
We are living in a world where elderly parents are increasingly distant from their relatives, as many relocate for work opportunities.
There are now more than 4 million people aged 65 and older who are living alone in the UK.
The series of national lockdowns during the coronavirus pandemic has made it even harder for people to check that those elderly loved ones are safe and well.
Families want peace of mind that their elderly relatives are living well, and are maintaining a relatively active lifestyle. Although we can call them to check ...
UNIVERSITY PARK, Pa. -- A team led by researchers in Penn State's College of Agricultural Sciences has developed a diagnostic test that can identify virulent forms of the swine bacterial pathogen Streptococcus equi subspecies zooepidemicus -- often referred to as "Strep zoo" -- which can cause severe illness and death in pigs, other animals and rarely people.
Outbreaks of S. zooepidemicus causing high mortality in swine first were reported in Asia in 1977, and until recently, the pathogen was not thought to be a major concern in North America. However, high-mortality Strep zoo outbreaks occurred in swine herds in Canada, Tennessee, Ohio and Pennsylvania in 2019. Different versions of the pathogen also can cause a range of disease symptoms ...
BOSTON - Patients who regurgitate regularly but without any known cause may have a condition called rumination. Unfortunately, rumination is often confused with other gastrointestinal conditions, which means many patients may not be getting prompt treatment. But a new study by investigators at Massachusetts General Hospital (MGH) in Neurogastroenterology and Motility clearly describes this syndrome, how to distinguish it from other conditions, and how to treat it.
Rumination syndrome is a behavioral problem, in which patients effortlessly and repeatedly regurgitate food into their mouths while eating and sitting upright. It is a learned behavior that is classified as a disorder ...
Announcing a new article publication for BIO Integration journal. In this review article the authors Yingxue Deng, Rui Huang, Songyin Huang and Menghua Xiong from South China University of Technology, Guangzhou, Guangdong, P. R. China and Sun Yat-sen University, Guangzhou, Guangdong, P. R. China discuss how nanoparticles enable efficient delivery of antimicrobial peptides for the treatment of deep infections.
Antimicrobial peptides (AMPs) are rarely directly used to treat deep infections due to their systemic toxicity and low bioavailability. The authors summarize recent progress that researchers employed nanoparticles based delivery systems to deliver AMPs for the treatment of deep infections.
Nanoparticles-based delivery systems offer a strategy ...
(Boston)-- Uncontrolled diabetes increases maternal and fetal risks during pregnancy. As a result, the American Diabetes Association (ADA) recommends that family planning should be discussed and effective contraception should be available to the more than three percent of (more than one million) reproductive-age women in the United States with diabetes. Yet a new study has found that women with diabetes are less likely to use contraception after their diabetes diagnosis.
"Efforts are needed to ensure that women with diabetes receive the counseling and clinical services needed to carefully plan their pregnancies," said corresponding author Mara Murray Horwitz, MD, assistant ...
When the COVID-19 pandemic forced medical students out of classrooms and clinical rotations this time last year, the state of Georgia's only public medical school had to quickly rethink its traditional curriculum.
Faculty and staff at the Medical College of Georgia at Augusta University were able to quickly adapt and provide an online platform for learning about the pandemic and initiating student-led service projects to aid frontline workers and help educate the public, MCG faculty and students write in a review article in the journal Medical Science Educator.
The University System of Georgia suspended in-classroom learning ...
Prior infection with COVID-19 protects most people against reinfection, with 0.65% of patients returning a positive PCR test twice during Denmark's first and second waves, compared with 3.27% of people who tested positive after initially being negative.
People over the age of 65 are at greater risk of catching COVID-19 again, with only 47% protection against repeat infection compared with 80% for younger people.
Protection against reinfection remained stable for more than six months.
The findings underline that measures to protect the elderly - including social distancing and vaccinations are essential even if people have already been diagnosed with COVID-19.
The analysis focused on the original COVID-19 strain and made no assessment ...
When it comes to adapting to new situations, goats are a step ahead. Compared to sheep, they can more quickly adapt to changing environmental conditions. These are the findings of a new study by researchers at Martin Luther University Halle-Wittenberg (MLU) and the Leibniz Institute for Farm Animal Biology (FBN) which were published in Royal Society Open Science. The study investigated how well the animals were able to navigate around obstacles to reach food.
Sheep and goats have many things in common: They are closely related genetically, roughly the same size, have similar social structures, and have both been domesticated by humans over approximately the same amount of time. They do, however, differ greatly when it comes to their foraging strategies. "While sheep ...
As their name suggests, by-the-wind sailor jellyfish know how to catch a breeze. Using a stiff, translucent sail propped an inch above the surface of the ocean, these teacup-sized organisms skim along the water dangling a fringe of delicate purple tentacles just below the surface to capture zooplankton and larval fish as they travel.
At the mercy of the wind, these jellies can wash ashore and strand -- sometimes numbering in the trillions -- on beaches around the world, including up and down the U.S. West Coast. And while these mass stranding events are hard to miss, very little actually is known about how or why they happen.
Now, thanks to 20 years of observations from thousands of citizen scientists, ...
